STOCK TITAN

ATIF Holdings Limited Announces Its Client Listing on the Nasdaq Global Market on January 12, 2021

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

ATIF Holdings Limited announced that its client, Qilian International Holding Group Limited, has officially launched its ordinary shares on the Nasdaq Global Market as of January 12, 2021. Qilian's initial public offering (IPO) priced 5,000,000 shares at $5.00 each, aiming for gross proceeds of $25 million. Additionally, underwriters have a 45-day option to purchase another 750,000 shares. Qilian operates in pharmaceutical and chemical production in China and has a broad market presence across various provinces.

Positive
  • Qilian's IPO successfully priced at $5.00 per share, raising $25 million.
  • Shares commenced trading on Nasdaq, increasing visibility and market access.
Negative
  • None.

LOS ANGELES, Calif., Jan. 12, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF, the "Group", "ATIF" or "we"), a company providing business consulting and media services in Asia and North America, announces the client of the Group, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding Group Limited (Nasdaq: QLI, "Qilian"), whose ordinary shares have been approved for listing on the Nasdaq Global Market and has commenced trading on January 12, 2021.

Qilian announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share on January 12, 2021. Qilian expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, Qilian has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.

About Qilian International Holding Group Limited
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Company's products are sold in more than 20 provinces in China. For more information, visit the company's website at http://ir.qlsyy.net.

About ATIF Holdings Limited
Headquartered in Los Angeles, California, ATIF Holdings Limited ("ATIF") is a holding group with asset management, investment holding and media services sectors and provide business consulting services to small and medium-sized enterprises in Asia and North America, including going public consulting services, international business planning and consulting services, and financial media services. ATIF operates an internet-based financial consulting service platform IPOEX.com, which provides prestige membership services including online capital market information, pre-IPO education and matchmaking services between SMEs and financing institutions. ATIF has advised several enterprises in China in their plans to become publicly listed in the U.S. For more information, please visit https://ir.atifchina.com/.

Forward-Looking Statements
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantee of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are: future financial and operating results, including revenues, income, expenditures, cash balances and other financial items; ability to manage growth and expansion; current and future economic and political conditions; ability to compete in an industry with low barriers to entry; ability to continue to operate through our VIE structure; ability to obtain additional financing in the future to fund capital expenditures; ability to attract new clients and further enhance brand recognition; ability to hire and retain qualified management personnel and key employees; trends and competition in the financial consulting services industry; a pandemic or epidemic; and other factors listed in the Company's annual report on Form 20-F and other documents filed with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions you that actual results may differ materially from the anticipated results expressed or implied by the forward-looking statements we make. You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management's beliefs and assumptions only as of the date such statements are made. These forward-looking statements are made as of the date of this news release.

 

 

Cision View original content:http://www.prnewswire.com/news-releases/atif-holdings-limited-announces-its-client-listing-on-the-nasdaq-global-market-on-january-12-2021-301206586.html

SOURCE ATIF Holdings Limited

FAQ

What is the significance of Qilian's IPO on January 12, 2021?

Qilian's IPO indicates its entry into the public markets, potentially increasing capital for growth.

How many shares did Qilian International Holding Group Limited offer?

Qilian offered 5,000,000 ordinary shares at a price of $5.00 per share.

What are the expected proceeds from Qilian's IPO?

Qilian anticipates gross proceeds of $25 million from its IPO.

Is there an option for underwriters to purchase more shares?

Yes, underwriters have a 45-day option to buy an additional 750,000 shares.

What type of products does Qilian manufacture?

Qilian specializes in pharmaceutical and chemical products, including licorice and oxytetracycline.

ATIF Holdings Limited Ordinary Shares

NASDAQ:ATIF

ATIF Rankings

ATIF Latest News

ATIF Stock Data

7.87M
11.92M
56.6%
0%
0.39%
Capital Markets
Services-management Consulting Services
Link
United States of America
SHENZHEN